Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839523 · ClinicalTrials.gov registry record · NA
Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns
A NA study of Partial-thickness Burn, sponsored by Molnlycke Health Care AB.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 6
- Study locations
NCT04839523 is a NA study of Partial-thickness Burn that is active but no longer recruiting, run by Molnlycke Health Care AB. The registered enrollment target is 44 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT04839523, a NA study of Partial-thickness Burn, is active but no longer recruiting, sponsored by Molnlycke Health Care AB.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 6
- Study locations
Study Summary
This a multi-center, open label, non-comparative, study that will evaluate the clinical safety and performance of Exufiber Ag+ and Exufiber dressings, separately, when used as intended in moderate to high exuding partial thickness burns (PTBs) through assessment of wound progression from baseline to the Subject's last clinical follow-up visit. Sixty-eight (68) eligible subjects, with moderate to high exuding partial-thickness burns, will be selected for treatment with either Exufiber Ag+ silver-coated gelling dressing, or Exufiber gelling dressing. The study will last 5 weeks, with a requirement of 5 study visits in total, including dressing changes at each study visit.
Conditions Studied
Interventions
- DEVICE Exufiber
- DEVICE Exufiber Ag+
Study Locations (6)
Arizona
- Arizona Burn Center, Valleywise Health - Phoenix
California
- Keck Medical Center of USC - Los Angeles
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Florida
- University of South Florida-Tampa General Hospital - Tampa
Massachusetts
- Massachusetts General Hospital - Boston
Pennsylvania
- Drexel Univerisity - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04839523
The ClinicalTrials.gov registry entry for NCT04839523 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Partial-thickness Burn appearing as the primary indexed condition, and to 2 interventions - of which Exufiber is the first listed.
NCT04839523 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04839523 about?
NCT04839523 is a clinical study titled "Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns". This a multi-center, open label, non-comparative, study that will evaluate the clinical safety and performance of Exufiber Ag+ and Exufiber dressings, separately, when used as intended in moderate to high exuding partial thickness burns (PTBs) through assessment of wound progression from baseline to...
What is the current status of trial NCT04839523?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2021-03-10. Estimated completion is 2024-12-31.
What conditions does trial NCT04839523 study?
This clinical trial studies the following conditions: Partial-thickness Burn.
What interventions are being tested in trial NCT04839523?
The interventions under investigation include: Exufiber (DEVICE), Exufiber Ag+ (DEVICE).
Who is sponsoring clinical trial NCT04839523?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04839523 being conducted?
This trial has 6 study locations across Arizona, California, District of Columbia, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Partial-thickness Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.